Metraipolis › archive › dc_c3ed5a753b8a

Identification of Mannose-Capped-Arabinomannan 101-mer as a Potential Influenza Virus Vaccine Adjuvant — Europe PMC PMID:41632009

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41632009
DOI
10.1002/advs.202519843
License (as archived)
solo-consultazione
Archived
2026-11-06T04:02:09.999Z
SHA-256 of the archived text
9d3116c6cf52911b861e2c90c40886180b7db34de45c9961501d29ca9566aa1b
Stable URL of this page
https://metraipolis.com/documento/dc_c3ed5a753b8a

How to cite

Identification of Mannose-Capped-Arabinomannan 101-mer as a Potential Influenza Virus Vaccine Adjuvant — Europe PMC PMID:41632009 — Europe PMC (en), https://europepmc.org/article/MED/41632009 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c3ed5a753b8a (Metraipolis archive dc_c3ed5a753b8a, sha256 9d3116c6cf52911b861e2c90c40886180b7db34de45c9961501d29ca9566aa1b)
BibTeX
@misc{dcc3ed5a753b8a,
  title = {Identification of Mannose-Capped-Arabinomannan 101-mer as a Potential Influenza Virus Vaccine Adjuvant — Europe PMC PMID:41632009},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41632009},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c3ed5a753b8a; sha256 9d3116c6cf52911b861e2c90c40886180b7db34de45c9961501d29ca9566aa1b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41632009. Agents can read the archived copy with the MCP tool read_document.